PDF(Pubmed)
Abstract：
UNASSIGNED: Depression in people with diabetes is associated with poorer health outcomes. Although web programs integrating cognitive-behavioral therapy with diabetes education have shown good results, no similar approach has been implemented in Spain. This aim of this study was to administer an Internet-based cognitive-behavioral therapy program (CBT) for the treatment of mild-moderate depressive symptomatology in individuals with type 1 diabetes (WEB_TDDI1 study) and evaluate the efficacy of this program.
UNASSIGNED: A pre-post randomized controlled study was conducted. The sample comprised 65 people with type 1 diabetes and mild-moderate depressive symptoms: 35 treatment group (TG) and 30 control group (CG). The following effects of the nine-session program were analyzed: depression (Beck Depression Inventory Fast Screen, BDI-FS), metabolic variables (glycosilated hemoglobin, HbA1c), and other psychological variables including anxiety (State Trait Anxiety Inventory, STAI), fear of hypoglycemia (Fear of Hypoglycemia Questionnaire, FH-15), distress (Diabetes Distress Questionnaire (DDS), quality of life (Diabetes Quality of Life Questionnaire, DQOL),and treatment adherence (Diabetes Self-Care Inventory-Revised questionnaire, SCI-R).
UNASSIGNED: At the end of the treatment program, only 28 people were evaluated (TG=8; CG=20). However, a significant reduction was found in both groups in BDI-FS and STAI-T scores, which was significantly greater in the TG. Significant improvements were also found in the TG in DQOL, FH-15, DDS and SCI-R scores. The percentage change in these variables was also statistically significant in the TG versus the CG. However, no significant results were found in HbA1c.
UNASSIGNED: The Internet-based cognitive-behavioral therapy program for the treatment of mild-moderate depressive symptomatology in people with type 1 diabetes (WEB_TDDI1 study) is effective in reducing depressive symptomatology in the sample that completed the study. Positive results are also produced in other variables associated with depression in this population such as diabetes-related distress, trait anxiety, fear of hypoglycemia, quality of life, and adherence to diabetes treatment. Although new studies would be necessary to support the results of this platform, the results obtained are positive and support the use of this platform as an appropriate treatment for this population.
UNASSIGNED: ClinicalTrials.gov; identifier NCT03473704.
UNASSIGNED: A pre-post randomized controlled study was conducted. The sample comprised 65 people with type 1 diabetes and mild-moderate depressive symptoms: 35 treatment group (TG) and 30 control group (CG). The following effects of the nine-session program were analyzed: depression (Beck Depression Inventory Fast Screen, BDI-FS), metabolic variables (glycosilated hemoglobin, HbA1c), and other psychological variables including anxiety (State Trait Anxiety Inventory, STAI), fear of hypoglycemia (Fear of Hypoglycemia Questionnaire, FH-15), distress (Diabetes Distress Questionnaire (DDS), quality of life (Diabetes Quality of Life Questionnaire, DQOL),and treatment adherence (Diabetes Self-Care Inventory-Revised questionnaire, SCI-R).
UNASSIGNED: At the end of the treatment program, only 28 people were evaluated (TG=8; CG=20). However, a significant reduction was found in both groups in BDI-FS and STAI-T scores, which was significantly greater in the TG. Significant improvements were also found in the TG in DQOL, FH-15, DDS and SCI-R scores. The percentage change in these variables was also statistically significant in the TG versus the CG. However, no significant results were found in HbA1c.
UNASSIGNED: The Internet-based cognitive-behavioral therapy program for the treatment of mild-moderate depressive symptomatology in people with type 1 diabetes (WEB_TDDI1 study) is effective in reducing depressive symptomatology in the sample that completed the study. Positive results are also produced in other variables associated with depression in this population such as diabetes-related distress, trait anxiety, fear of hypoglycemia, quality of life, and adherence to diabetes treatment. Although new studies would be necessary to support the results of this platform, the results obtained are positive and support the use of this platform as an appropriate treatment for this population.
UNASSIGNED: ClinicalTrials.gov; identifier NCT03473704.
摘要：
■糖尿病患者的抑郁与较差的健康结果相关。尽管将认知行为疗法与糖尿病教育相结合的网络程序已显示出良好的效果，西班牙没有实施类似的方法。这项研究的目的是管理一个基于互联网的认知行为治疗计划（CBT），用于治疗1型糖尿病患者的轻度-中度抑郁症状（WEB_TDDI1研究），并评估该计划的有效性。
■进行了一项预随机对照研究。样本包括65名患有1型糖尿病和轻度-中度抑郁症状的人：35名治疗组（TG）和30名对照组（CG）。分析了九期计划的以下效果：抑郁(贝克抑郁量表快速筛选，BDI-FS)，代谢变量(糖基化血红蛋白，HbA1c），和其他心理变量，包括焦虑(状态特质焦虑量表，STAI),对低血糖的恐惧(对低血糖的恐惧问卷，FH-15),困扰(糖尿病困扰问卷(DDS)，生活质量(糖尿病生活质量问卷，DQOL)，和治疗依从性(糖尿病自我护理量表-修订问卷，SCI-R）。
■在治疗方案结束时，仅对28人进行了评估(TG=8;CG=20).然而,两组BDI-FS和STAI-T评分均显著降低，在TG中明显更大。DQOL中的TG也有显著改善，FH-15、DDS和SCI-R评分。这些变量的百分比变化在TG与CG中也具有统计学意义。然而,在HbA1c中没有发现显著结果.
■基于互联网的认知行为治疗计划，用于治疗1型糖尿病患者的轻度-中度抑郁症状（WEB_TDDI1研究）可有效减少完成研究的样本中的抑郁症状。在这个人群中，与抑郁相关的其他变量也产生了积极的结果，例如与糖尿病相关的痛苦，特质焦虑,对低血糖的恐惧，生活质量,坚持糖尿病治疗。尽管有必要进行新的研究来支持该平台的结果，获得的结果是积极的,支持将该平台用作该人群的适当治疗.
■ClinicalTrials.gov；标识符NCT03473704。
■进行了一项预随机对照研究。样本包括65名患有1型糖尿病和轻度-中度抑郁症状的人：35名治疗组（TG）和30名对照组（CG）。分析了九期计划的以下效果：抑郁(贝克抑郁量表快速筛选，BDI-FS)，代谢变量(糖基化血红蛋白，HbA1c），和其他心理变量，包括焦虑(状态特质焦虑量表，STAI),对低血糖的恐惧(对低血糖的恐惧问卷，FH-15),困扰(糖尿病困扰问卷(DDS)，生活质量(糖尿病生活质量问卷，DQOL)，和治疗依从性(糖尿病自我护理量表-修订问卷，SCI-R）。
■在治疗方案结束时，仅对28人进行了评估(TG=8;CG=20).然而,两组BDI-FS和STAI-T评分均显著降低，在TG中明显更大。DQOL中的TG也有显著改善，FH-15、DDS和SCI-R评分。这些变量的百分比变化在TG与CG中也具有统计学意义。然而,在HbA1c中没有发现显著结果.
■基于互联网的认知行为治疗计划，用于治疗1型糖尿病患者的轻度-中度抑郁症状（WEB_TDDI1研究）可有效减少完成研究的样本中的抑郁症状。在这个人群中，与抑郁相关的其他变量也产生了积极的结果，例如与糖尿病相关的痛苦，特质焦虑,对低血糖的恐惧，生活质量,坚持糖尿病治疗。尽管有必要进行新的研究来支持该平台的结果，获得的结果是积极的,支持将该平台用作该人群的适当治疗.
■ClinicalTrials.gov；标识符NCT03473704。
